Cryptyx Bioscience
Princeton
About Cryptyx Bioscience
Cryptyx Bioscience is a genetics-free, cloning-free, bioactivity-first platform for accessing hidden therapeutic natural products encoded in bacteria. They utilize a natural product drug discovery platform aimed at activating silent biosynthetic gene clusters in bacteria and at unlocking the full potential of any culturable microbe.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $256.0K
- Last round: Grant (Apr 2022)
- Website: cryptyxbioscience.com
Industries & Categories
Biotechnology, Pharmaceutical, Product Research
Social Profiles
Canonical: https://fsome.com/organization/cryptyx-bioscience-172887 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.